Clinical Trials in North Carolina

Showing 2721-2740 of 17,526 trials

Narrative Medicine Effects on Burnout and Stress

NCT07136597

A rising area of interest over the past several years has been on the issue of physician burnout. Burnout can be defined as a chronic occupational stress response characterized by multi-dimensional exhaustion and diminished sense of fulfillment in one's personal and professional life. Regarding the effects of emotional, occupational and physical stress on job satisfaction, standard of care and staff retention, it is important to determine meaningful methods to alleviate and prevent burnout among healthcare professionals.

Healthcare Professionals

Wake Forest University Health Sciences60 participantsStarted Mar 2026

Winston-Salem, North Carolina, United States

Enrolling By InvitationPhase 2/341 miles

HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP

NCT05883748

This is an open-label, long-term extension study to investigate the safety, tolerability and efficacy of DISC-1459 in participants with EPP.

Erythropoietic Protoporphyria

Disc Medicine, Inc230 participantsStarted Aug 2023

Birmingham, Alabama, United States • San Francisco, California, United States • Miami, Florida, United States +10 more locations

Narrative Medicine Effects on Burnout and Stress

HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP

Find Trials by Condition in North Carolina

A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)

Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter

A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome

A Peer-Led Intervention to Improve Postpartum Retention in HIV Care

A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled Hypertension

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers

Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma

A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population

A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS

Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)

Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX

24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDG